AMGN — AMGEN INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 318154 ·
Last close
$416.18
Market Cap
$224.62B
52W High
$421.79
52W Low
$320.97
ADV30
2,489,058
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 10,054,000,000 | 7,243,000,000 | 3,514,000,000 | 2,375,000,000 | 95,639,000,000 | 13,989,000,000 | 83,951,000,000 |
| Mar 2026 | 8,618,000,000 | 5,874,000,000 | 2,666,000,000 | 1,819,000,000 | 92,504,000,000 | 12,038,000,000 | 83,314,000,000 |
| Dec 2025 | 9,866,000,000 | 6,890,000,000 | 2,720,000,000 | 1,333,000,000 | 90,586,000,000 | 9,129,000,000 | 81,928,000,000 |
| Sep 2025 | 9,557,000,000 | 6,475,000,000 | 2,526,000,000 | 3,216,000,000 | 90,141,000,000 | 9,445,000,000 | 80,522,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$10,756,000,000
Investing CF
$-2,212,000,000
Financing CF
$-5,316,000,000
CapEx
$-2,159,000,000
Dividends Paid
$-5,203,000,000
Buybacks
—
EPS Diluted TTM
$14.37
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-22,275,000,000
Inventory
$6,220,000,000
Receivables
$10,227,000,000
ST Investments
—
EBIT TTM
$12,955,000,000
Pretax Income TTM
$10,287,000,000
Interest Exp TTM
$2,668,000,000
Analysts
29
Yahoo Snapshot (yfinance, live)
Total Revenue
$38,094,999,552
EBITDA
$17,268,000,768
Free Cash Flow
$8,645,624,832
Enterprise Value
$267,298,832,384
Total Cash
$13,989,000,192
Total Debt
$57,303,998,464
Shares Out
539,708,274
Trailing EPS
$16.19
Book Value
$21.62
ROE
91.5%
ROA
8.7%
Div Yield
2.43%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 36,751,000,000 | 9,080,000,000 | 7,711,000,000 | 90,586,000,000 | 81,928,000,000 | — | 9,958,000,000 |
| Dec 2024 | 33,424,000,000 | 7,258,000,000 | 4,090,000,000 | 91,839,000,000 | 85,962,000,000 | — | 11,490,000,000 |
| Dec 2023 | 28,190,000,000 | 7,897,000,000 | 6,717,000,000 | 97,154,000,000 | 90,922,000,000 | — | 8,471,000,000 |
| Dec 2022 | 26,323,000,000 | 9,566,000,000 | 6,552,000,000 | 65,121,000,000 | 61,460,000,000 | — | 9,721,000,000 |
TTM Snapshot
Revenues TTM
$28,764,000,000
NetIncome TTM
$8,587,000,000
OpCashFlow TTM
$0
Assets (Latest)
$91,839,000,000
Forward EPS
$24.22
Max Pain — expiry 2026-08-21
max pain strike: $375.00 · spot: $417.55 · call oi: 10,198 · put oi: 12,533
Expected Move to 2026-08-21:
±$13.18
(3.16%) —
implied range
$404.37 –
$430.72
· ATM straddle on $420.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GILD | GILEAD SCIENCES, INC. | $168.47B | $135.87 | — |
| ARGX | ARGENX SE | $54.80B | $876.00 | — |
| RVMD | Revolution Medicines, Inc. | $43.99B | $205.26 | — |
| BIIB | BIOGEN INC. | $30.86B | $208.87 | — |
| MRNA | Moderna, Inc. | $25.42B | $63.67 | — |
News headlines (Yahoo Finance, 1h cache)
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover
2026-08-13 13:05 · Yahoo
Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions
2026-08-13 08:05 · Yahoo
BeOne Medicines Ltd (ONC) (Q2 2026) Earnings Call Highlights: Revenue Surges 30% to $1. ...
2026-08-13 01:04 · Yahoo
Amgen Stock And The Price Of A Promise
2026-08-12 19:17 · Yahoo
AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD
2026-08-12 08:25 · Yahoo
Amgen (AMGN) Q2 2026 Earnings Call Transcript
2026-08-11 23:57 · Yahoo
Dividend Stocks That Are Paying Investors Cash
2026-08-11 17:56 · Yahoo
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
2026-08-11 13:20 · Yahoo
What Analysts Really Pressed LLY On This Quarter
2026-08-10 23:01 · Yahoo
Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY
2026-08-10 18:07 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.